書誌事項
- タイトル別名
-
- Antibiotic prophylaxis in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma
- カン ドウミャク カガク ソクセン リョウホウジ ノ ヨボウテキ コウセイザイ トウヨ ニ カンスル ケントウ : ケイコウザイ ト チュウシャザイ ノ ヒカク
この論文をさがす
抄録
Aim/background: Antibiotic prophylaxis is widely used in transcatheter arterial chemoembolization (TACE) for advanced hepatocellular carcinoma (HCC). The usefulness of oral antibiotic prophylaxis in TACE has not been established. Material/methods: One hundred forty five HCC, 76 were given oral levofloxacin (LVFX) (PO group) and 69 were administrated with cefotiam (CTM) by intravenous infusion as a historical control (DIV group), were enrolled. We investigated the clinical course and backgrounds of both groups, retrospectively. Results: There are no significant differences in clinical backgrounds, periods of hospitalization and administrating antibiotic drugs between both groups. The cost of antibiotic drugs were significant lower in PO than DIV group (3277.1 vs. 11924.4 yen, P<0.01). Conclusion: Oral LVFX was useful and a low cost medication for preventing infection after TACE.
収録刊行物
-
- 肝臓
-
肝臓 54 (10), 713-715, 2013
一般社団法人 日本肝臓学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204793947264
-
- NII論文ID
- 130003384478
-
- NII書誌ID
- AN00047770
-
- ISSN
- 18813593
- 04514203
-
- NDL書誌ID
- 024936626
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可